A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy
Titel:
A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy
Auteur:
Brandwein, Joseph M. Seki, Jack T. Atenafu, Eshetu G. Rostom, Amr Lutynski, Andrzej Rydlewski, Anna Schimmer, Aaron D. Schuh, Andre C. Gupta, Vikas Yee, Karen W. L.